Federal Register #2026-14837

DEA Proposed Information Collection for Electronic Prescription Transfers (Schedules III-V)

This notice from the Department of Justice's Drug Enforcement Administration (DEA) concerns a proposed revision to information collection requirements for electronic prescription transfers of controlled substances (Schedules III-V). - Government Buyer: - Department of Justice (DOJ) - Drug Enforcement Administration (DEA) - OEMs and Vendors: - DEA is the only entity mentioned; no commercial OEMs or vendors are involved - Products/Services Requested: - No products or services are being procured or awarded - The notice addresses regulatory requirements for pharmacies transferring electronic prescriptions - Unique or Notable Requirements: - Pharmacies must update electronic prescription records with: - Names, addresses, and DEA registration numbers of both transferring and receiving pharmacies - Names of the pharmacists involved - Date of transfer - The DEA is seeking public comment on the necessity, burden, and methodology of these recordkeeping requirements - This is a regulatory information collection notice, not a procurement or contract opportunity

Description

This notice pertains to the submission of a request for review and approval of information collection activities related to the transfer of electronic prescriptions in Schedule III-V drugs between pharmacies, as part of the DEA's regulatory activities. The information collection requires pharmacies to update electronic prescription records with details of the transfer, including names, addresses, DEA registration numbers, and dates. The Drug Enforcement Administration (DEA), Department of Justice, is seeking comments on this proposed collection. The collection aims to ensure proper recordkeeping for controlled substances transfers between pharmacies.

View original listing